Circulating miR-499 as a potential biomarker for acute myocardial infarction

Annals of Translational Medicine

Volumn 4, Issue 7, 2016, Pages

  Xin, Yunyi ^a   Yang, Chengjian ^a   Han, Zhijun ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Acute myocardial infarction (AMI); Biomarker; MiRNA 499

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; MICRORNA; MICRORNA 133A; MICRORNA 208; MICRORNA 449; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; MORTALITY RISK; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS;

EID: 85006219383     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.21037/atm.2016.03.40     Document Type: Review

References (36)

1. Romaine SP, Tomaszewski M, Condorelli G, et al. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart 2015;101:921-8.
2. Kaur S, Krishn SR, Rachagani S, et al. Significance of microRNA-based biomarkers for pancreatic cancer. Ann Transl Med 2015;3:277.
3. Schulte C, Zeller T. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther 2015;5:17-36.
4. Condorelli G, Latronico MV, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol 2014;63:2177-87.
5. Sayed AS, Xia K, Yang TL, Peng J. Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis Markers 2013;35:561-6.
6. Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011;4:446-54.
7. Widera C, Gupta SK, Lorenzen JM, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51:872-5.
8. D'Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31:2765-73.
9. Olivieri F, Antonicelli R, Spazzafumo L, et al. Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction. Int J Cardiol 2014;172:e276-8.
10. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 2010;119:87-95.
11. Yao Y, Du J, Cao X, et al. Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients. PLoS One 2014;9:e104618.
12. Basheer WA, Harris BS, Mentrup HL, et al. Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis. J Mol Cell Cardiol 2015;88:1-13.
13. Clark AL, Naya FJ. MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2. J Biol Chem 2015;290:23162-72.
14. Chen C, Yang S, Chaugai S, et al. Meta-analysis of Hsamir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies. BMC Med Genet 2014;15:126.
15. Wang JX, Jiao JQ, Li Q, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 2011;17:71-8.
16. Wilson KD, Hu S, Venkatasubrahmanyam S, et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 2010;3:426-35.
17. Fiedler J, Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol 2013;33:201-5.
18. Hosoda T, Zheng H, Cabral-da-Silva M, et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 2011;123:1287-96.
19. Adachi T, Nakanishi M, Otsuka Y, et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010;56:1183-5.
20. Zhang L, Chen X, Su T, et al. Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J Thorac Dis 2015;7:303-8.
21. Chen X, Zhang L, Su T, et al. Kinetics of plasma microRNA-499 expression in acute myocardial infarction. J Thorac Dis 2015;7:890-6.
22. Olivieri F, Antonicelli R, Lorenzi M, et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 2013;167:531-6.
23. Li YQ, Zhang MF, Wen HY, et al. Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics (Sao Paulo) 2013;68:75-80.
24. Gidlöf O, Smith JG, Miyazu K, et al. Circulating cardio-enriched microRNAs are associated with longterm prognosis following myocardial infarction. BMC Cardiovasc Disord 2013;13:12.
25. Nachtigall PG, Dias MC, Carvalho RF, et al. MicroRNA-499 expression distinctively correlates to target genes sox6 and rod1 profiles to resolve the skeletal muscle phenotype in Nile tilapia. PLoS One 2015;10:e0119804.
26. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010;31:659-66.
27. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110:13-21.
28. Rabinowits G, Gerçel-Taylor C, Day JM, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009;10:42-6.
29. Zhao CH, Cheng GC, He RL, et al. Analysis and clinical significance of microRNA-499 expression levels in serum of patients with acute myocardial infarction. Genet Mol Res 2015;14:4027-34.
30. Devaux Y, Vausort M, Goretti E, et al. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 2012;58:559-67.
31. Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010;50:298-301.
32. Xiang M, Zeng Y, Yang R, et al. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun 2014;454:210-4.
33. Ling TY, Wang XL, Chai Q, et al. Regulation of the SK3 channel by microRNA-499-potential role in atrial fibrillation. Heart Rhythm 2013;10:1001-9.
34. Matkovich SJ, Hu Y, Eschenbacher WH, et al. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res 2012;111:521-31.
35. Fan C, Chen C, Wu D. The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis. Mol Biol Rep 2013;40:3389-94.
36. Lu L, Tu Y, Liu L, et al. MicroRNA-499 rs3746444 polymorphism and autoimmune diseases risk: a metaanalysis. Mol Diagn Ther 2014;18:237-42.